The Company of Biologists is delighted to announce a three-year Read & Publish Open Access agreement with the Bibsam Consortium which runs from 1 January 2022 to 31 December 2024.
Corresponding authors at participating institutions in Sweden can publish an uncapped number of research articles immediately Open Access (OA) in our hybrid subscription journals (Development, Journal of Cell Science and Journal of Experimental Biology) plus our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC).
Researchers at participating institutions also benefit from unlimited access to our hybrid subscription journals, including their full archives dating back to 1853.
Anna Lundén, Acting Director, Libraries Collaboration and Research Support Department, National Library of Sweden, says:
“We are very pleased with the new Read & Publish agreement between The Company of Biologists and the Bibsam Consortium, covering costs for Swedish researchers at participating institutions to publish an unlimited number of Open Access articles in all five of The Company of Biologists’ journals, whilst also giving them read access. To sign transformative agreements with small not-for-profit publishers is an important step in line with our action plan to advance Open Science.”
Rich Blount, Regional Sales Manager at The Company of Biologists, says:
“Our Read & Publish Open Access initiative continues to go from strength to strength. Over 470 institutions in more than 30 countries are now participating and we have signed agreements with nine library consortia and an international library organisation.
We are excited about our new partnership with the Bibsam Consortium, particularly as it is also our first ever consortium agreement in Scandinavia. We are also very pleased that five institutions have already signed up.”
Claire Moulton, Publisher at The Company of Biologists, says:
“As a not-for-profit publisher dedicated to supporting the biological community worldwide, we have been committed to Open Access for over 17 years.
Our journals were the first in the world to be awarded Transformative Journal status by Plan S and the success of our Read & Publish initiative has already driven a significant increase in Open Access research content in our hybrid subscription journals.
We welcome our new Read & Publish agreement with the Bibsam Consortium and look forward to working together to promote the growth of Open Access publishing in the biological and biomedical sciences in Sweden.”